Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Other financing activities: 2021-2024

Historic Other financing activities for Journey Medical (DERM) over the last 4 years, with Dec 2024 value amounting to $50,000.

  • Journey Medical's Other financing activities rose 342.04% to $380,000 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.1 million, marking a year-over-year increase of 23.45%. This contributed to the annual value of $50,000 for FY2024, which is 89.38% down from last year.
  • According to the latest figures from FY2024, Journey Medical's Other financing activities is $50,000, which was down 89.38% from $471,000 recorded in FY2023.
  • Over the past 5 years, Journey Medical's Other financing activities peaked at $2.0 million during FY2021, and registered a low of $50,000 during FY2024.
  • Its 3-year average for Other financing activities is $245,000, with a median of $214,000 in 2022.
  • Per our database at Business Quant, Journey Medical's Other financing activities spiked by 120.09% in 2023 and then slumped by 89.38% in 2024.
  • Yearly analysis of 4 years shows Journey Medical's Other financing activities stood at $2.0 million in 2021, then crashed by 89.28% to $214,000 in 2022, then skyrocketed by 120.09% to $471,000 in 2023, then tumbled by 89.38% to $50,000 in 2024.